Rankings
▼
Calendar
ORIC Q2 2024 Earnings — ORIC Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
ORIC
ORIC Pharmaceuticals, Inc.
$1B
Q2 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$36M
Net Income
-$32M
EPS (Diluted)
$-0.45
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$26M
Free Cash Flow
-$26M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$329M
Total Liabilities
$27M
Stockholders' Equity
$302M
Cash & Equivalents
$50M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$36M
-$25M
-44.1%
Net Income
-$32M
-$23M
-39.3%
← FY 2024
All Quarters
Q3 2024 →